Table of Content

1 Granulocytes Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of Granulocytes Monoclonal Antibody
1.2 Granulocytes Monoclonal Antibody Segment by Type
1.2.1 Global Granulocytes Monoclonal Antibody Market Value Comparison by Type (2024-2034)
1.2.2 Recombinant
1.2.3 Non-recombinant
1.3 Granulocytes Monoclonal Antibody Segment by Application
1.3.1 Global Granulocytes Monoclonal Antibody Market Value by Application: (2024-2034)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Other
1.4 Global Granulocytes Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Granulocytes Monoclonal Antibody Revenue 2024-2034
1.4.2 Global Granulocytes Monoclonal Antibody Sales 2024-2034
1.4.3 Global Granulocytes Monoclonal Antibody Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Granulocytes Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Granulocytes Monoclonal Antibody Sales Market Share by Manufacturers (2024-2024)
2.2 Global Granulocytes Monoclonal Antibody Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Granulocytes Monoclonal Antibody Average Price by Manufacturers (2024-2024)
2.4 Global Granulocytes Monoclonal Antibody Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Granulocytes Monoclonal Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Granulocytes Monoclonal Antibody, Product Type & Application
2.7 Granulocytes Monoclonal Antibody Market Competitive Situation and Trends
2.7.1 Granulocytes Monoclonal Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Granulocytes Monoclonal Antibody Players Market Share by Revenue
2.7.3 Global Granulocytes Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Granulocytes Monoclonal Antibody Retrospective Market Scenario by Region
3.1 Global Granulocytes Monoclonal Antibody Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Granulocytes Monoclonal Antibody Global Granulocytes Monoclonal Antibody Sales by Region: 2024-2034
3.2.1 Global Granulocytes Monoclonal Antibody Sales by Region: 2024-2024
3.2.2 Global Granulocytes Monoclonal Antibody Sales by Region: 2024-2034
3.3 Global Granulocytes Monoclonal Antibody Global Granulocytes Monoclonal Antibody Revenue by Region: 2024-2034
3.3.1 Global Granulocytes Monoclonal Antibody Revenue by Region: 2024-2024
3.3.2 Global Granulocytes Monoclonal Antibody Revenue by Region: 2024-2034
3.4 North America Granulocytes Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America Granulocytes Monoclonal Antibody Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Granulocytes Monoclonal Antibody Sales by Country (2024-2034)
3.4.3 North America Granulocytes Monoclonal Antibody Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Granulocytes Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe Granulocytes Monoclonal Antibody Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Granulocytes Monoclonal Antibody Sales by Country (2024-2034)
3.5.3 Europe Granulocytes Monoclonal Antibody Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Granulocytes Monoclonal Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Granulocytes Monoclonal Antibody Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Granulocytes Monoclonal Antibody Sales by Country (2024-2034)
3.6.3 Asia Pacific Granulocytes Monoclonal Antibody Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Granulocytes Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America Granulocytes Monoclonal Antibody Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Granulocytes Monoclonal Antibody Sales by Country (2024-2034)
3.7.3 Latin America Granulocytes Monoclonal Antibody Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Granulocytes Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Granulocytes Monoclonal Antibody Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Granulocytes Monoclonal Antibody Sales by Country (2024-2034)
3.8.3 Middle East and Africa Granulocytes Monoclonal Antibody Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Granulocytes Monoclonal Antibody Sales by Type (2024-2034)
4.1.1 Global Granulocytes Monoclonal Antibody Sales by Type (2024-2024)
4.1.2 Global Granulocytes Monoclonal Antibody Sales by Type (2024-2034)
4.1.3 Global Granulocytes Monoclonal Antibody Sales Market Share by Type (2024-2034)
4.2 Global Granulocytes Monoclonal Antibody Revenue by Type (2024-2034)
4.2.1 Global Granulocytes Monoclonal Antibody Revenue by Type (2024-2024)
4.2.2 Global Granulocytes Monoclonal Antibody Revenue by Type (2024-2034)
4.2.3 Global Granulocytes Monoclonal Antibody Revenue Market Share by Type (2024-2034)
4.3 Global Granulocytes Monoclonal Antibody Price by Type (2024-2034)
5 Segment by Application
5.1 Global Granulocytes Monoclonal Antibody Sales by Application (2024-2034)
5.1.1 Global Granulocytes Monoclonal Antibody Sales by Application (2024-2024)
5.1.2 Global Granulocytes Monoclonal Antibody Sales by Application (2024-2034)
5.1.3 Global Granulocytes Monoclonal Antibody Sales Market Share by Application (2024-2034)
5.2 Global Granulocytes Monoclonal Antibody Revenue by Application (2024-2034)
5.2.1 Global Granulocytes Monoclonal Antibody Revenue by Application (2024-2024)
5.2.2 Global Granulocytes Monoclonal Antibody Revenue by Application (2024-2034)
5.2.3 Global Granulocytes Monoclonal Antibody Revenue Market Share by Application (2024-2034)
5.3 Global Granulocytes Monoclonal Antibody Price by Application (2024-2034)
6 Key Companies Profiled
6.1 LifeSpan BioSciences, Inc
6.1.1 LifeSpan BioSciences, Inc Corporation Information
6.1.2 LifeSpan BioSciences, Inc Description and Business Overview
6.1.3 LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.1.4 LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Product Portfolio
6.1.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Corporation Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Thermo Fisher Granulocytes Monoclonal Antibody Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 RayBiotech, Inc.
6.3.1 RayBiotech, Inc. Corporation Information
6.3.2 RayBiotech, Inc. Description and Business Overview
6.3.3 RayBiotech, Inc. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.3.4 RayBiotech, Inc. Granulocytes Monoclonal Antibody Product Portfolio
6.3.5 RayBiotech, Inc. Recent Developments/Updates
6.4 MyBiosource, Inc.
6.4.1 MyBiosource, Inc. Corporation Information
6.4.2 MyBiosource, Inc. Description and Business Overview
6.4.3 MyBiosource, Inc. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.4.4 MyBiosource, Inc. Granulocytes Monoclonal Antibody Product Portfolio
6.4.5 MyBiosource, Inc. Recent Developments/Updates
6.5 Shanghai Korain Biotech Co., Ltd.
6.5.1 Shanghai Korain Biotech Co., Ltd. Corporation Information
6.5.2 Shanghai Korain Biotech Co., Ltd. Description and Business Overview
6.5.3 Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product Portfolio
6.5.5 Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
6.6 Wuhan Fine Biotech Co., Ltd.
6.6.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.6.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.6.3 Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product Portfolio
6.6.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.7 CUSABIO
6.6.1 CUSABIO Corporation Information
6.6.2 CUSABIO Description and Business Overview
6.6.3 CUSABIO Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.4.4 CUSABIO Granulocytes Monoclonal Antibody Product Portfolio
6.7.5 CUSABIO Recent Developments/Updates
6.8 Boster Biological Technology
6.8.1 Boster Biological Technology Corporation Information
6.8.2 Boster Biological Technology Description and Business Overview
6.8.3 Boster Biological Technology Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Boster Biological Technology Granulocytes Monoclonal Antibody Product Portfolio
6.8.5 Boster Biological Technology Recent Developments/Updates
6.9 Biomatik
6.9.1 Biomatik Corporation Information
6.9.2 Biomatik Description and Business Overview
6.9.3 Biomatik Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Biomatik Granulocytes Monoclonal Antibody Product Portfolio
6.9.5 Biomatik Recent Developments/Updates
6.10 Assay Genie
6.10.1 Assay Genie Corporation Information
6.10.2 Assay Genie Description and Business Overview
6.10.3 Assay Genie Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Assay Genie Granulocytes Monoclonal Antibody Product Portfolio
6.10.5 Assay Genie Recent Developments/Updates
6.11 Abbexa
6.11.1 Abbexa Corporation Information
6.11.2 Abbexa Granulocytes Monoclonal Antibody Description and Business Overview
6.11.3 Abbexa Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Abbexa Granulocytes Monoclonal Antibody Product Portfolio
6.11.5 Abbexa Recent Developments/Updates
6.12 CLOUD-CLONE CORP.
6.12.1 CLOUD-CLONE CORP. Corporation Information
6.12.2 CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Description and Business Overview
6.12.3 CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.12.4 CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Product Portfolio
6.12.5 CLOUD-CLONE CORP. Recent Developments/Updates
6.13 Innovative Research
6.13.1 Innovative Research Corporation Information
6.13.2 Innovative Research Granulocytes Monoclonal Antibody Description and Business Overview
6.13.3 Innovative Research Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Innovative Research Granulocytes Monoclonal Antibody Product Portfolio
6.13.5 Innovative Research Recent Developments/Updates
6.14 ZodelBiotec Ltd.
6.14.1 ZodelBiotec Ltd. Corporation Information
6.14.2 ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Description and Business Overview
6.14.3 ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
6.14.4 ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Product Portfolio
6.14.5 ZodelBiotec Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Granulocytes Monoclonal Antibody Industry Chain Analysis
7.2 Granulocytes Monoclonal Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Granulocytes Monoclonal Antibody Production Mode & Process
7.4 Granulocytes Monoclonal Antibody Sales and Marketing
7.4.1 Granulocytes Monoclonal Antibody Sales Channels
7.4.2 Granulocytes Monoclonal Antibody Distributors
7.5 Granulocytes Monoclonal Antibody Customers
8 Granulocytes Monoclonal Antibody Market Dynamics
8.1 Granulocytes Monoclonal Antibody Industry Trends
8.2 Granulocytes Monoclonal Antibody Market Drivers
8.3 Granulocytes Monoclonal Antibody Market Challenges
8.4 Granulocytes Monoclonal Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Granulocytes Monoclonal Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Granulocytes Monoclonal Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Granulocytes Monoclonal Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global Granulocytes Monoclonal Antibody Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Granulocytes Monoclonal Antibody Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Granulocytes Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Granulocytes Monoclonal Antibody Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Granulocytes Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Granulocytes Monoclonal Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Granulocytes Monoclonal Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Granulocytes Monoclonal Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Granulocytes Monoclonal Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Granulocytes Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granulocytes Monoclonal Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Granulocytes Monoclonal Antibody Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Granulocytes Monoclonal Antibody Sales by Region (2024-2024) & (K Units)
Table 18. Global Granulocytes Monoclonal Antibody Sales Market Share by Region (2024-2024)
Table 19. Global Granulocytes Monoclonal Antibody Sales by Region (2024-2034) & (K Units)
Table 20. Global Granulocytes Monoclonal Antibody Sales Market Share by Region (2024-2034)
Table 21. Global Granulocytes Monoclonal Antibody Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Granulocytes Monoclonal Antibody Revenue Market Share by Region (2024-2024)
Table 23. Global Granulocytes Monoclonal Antibody Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Granulocytes Monoclonal Antibody Revenue Market Share by Region (2024-2034)
Table 25. North America Granulocytes Monoclonal Antibody Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 27. North America Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 28. North America Granulocytes Monoclonal Antibody Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Granulocytes Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Granulocytes Monoclonal Antibody Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 32. Europe Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 33. Europe Granulocytes Monoclonal Antibody Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Granulocytes Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Granulocytes Monoclonal Antibody Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Granulocytes Monoclonal Antibody Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Granulocytes Monoclonal Antibody Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Granulocytes Monoclonal Antibody Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Granulocytes Monoclonal Antibody Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Granulocytes Monoclonal Antibody Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Granulocytes Monoclonal Antibody Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Granulocytes Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Granulocytes Monoclonal Antibody Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Granulocytes Monoclonal Antibody Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Granulocytes Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Granulocytes Monoclonal Antibody Sales (K Units) by Type (2024-2024)
Table 51. Global Granulocytes Monoclonal Antibody Sales (K Units) by Type (2024-2034)
Table 52. Global Granulocytes Monoclonal Antibody Sales Market Share by Type (2024-2024)
Table 53. Global Granulocytes Monoclonal Antibody Sales Market Share by Type (2024-2034)
Table 54. Global Granulocytes Monoclonal Antibody Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Granulocytes Monoclonal Antibody Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Granulocytes Monoclonal Antibody Revenue Market Share by Type (2024-2024)
Table 57. Global Granulocytes Monoclonal Antibody Revenue Market Share by Type (2024-2034)
Table 58. Global Granulocytes Monoclonal Antibody Price (US$/Unit) by Type (2024-2024)
Table 59. Global Granulocytes Monoclonal Antibody Price (US$/Unit) by Type (2024-2034)
Table 60. Global Granulocytes Monoclonal Antibody Sales (K Units) by Application (2024-2024)
Table 61. Global Granulocytes Monoclonal Antibody Sales (K Units) by Application (2024-2034)
Table 62. Global Granulocytes Monoclonal Antibody Sales Market Share by Application (2024-2024)
Table 63. Global Granulocytes Monoclonal Antibody Sales Market Share by Application (2024-2034)
Table 64. Global Granulocytes Monoclonal Antibody Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Granulocytes Monoclonal Antibody Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Granulocytes Monoclonal Antibody Revenue Market Share by Application (2024-2024)
Table 67. Global Granulocytes Monoclonal Antibody Revenue Market Share by Application (2024-2034)
Table 68. Global Granulocytes Monoclonal Antibody Price (US$/Unit) by Application (2024-2024)
Table 69. Global Granulocytes Monoclonal Antibody Price (US$/Unit) by Application (2024-2034)
Table 70. LifeSpan BioSciences, Inc Corporation Information
Table 71. LifeSpan BioSciences, Inc Description and Business Overview
Table 72. LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Product
Table 74. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 75. Thermo Fisher Corporation Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Thermo Fisher Granulocytes Monoclonal Antibody Product
Table 79. Thermo Fisher Recent Developments/Updates
Table 80. RayBiotech, Inc. Corporation Information
Table 81. RayBiotech, Inc. Description and Business Overview
Table 82. RayBiotech, Inc. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. RayBiotech, Inc. Granulocytes Monoclonal Antibody Product
Table 84. RayBiotech, Inc. Recent Developments/Updates
Table 85. MyBiosource, Inc. Corporation Information
Table 86. MyBiosource, Inc. Description and Business Overview
Table 87. MyBiosource, Inc. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. MyBiosource, Inc. Granulocytes Monoclonal Antibody Product
Table 89. MyBiosource, Inc. Recent Developments/Updates
Table 90. Shanghai Korain Biotech Co., Ltd. Corporation Information
Table 91. Shanghai Korain Biotech Co., Ltd. Description and Business Overview
Table 92. Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product
Table 94. Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
Table 95. Wuhan Fine Biotech Co., Ltd. Corporation Information
Table 96. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
Table 97. Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product
Table 99. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 100. CUSABIO Corporation Information
Table 101. CUSABIO Description and Business Overview
Table 102. CUSABIO Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. CUSABIO Granulocytes Monoclonal Antibody Product
Table 104. CUSABIO Recent Developments/Updates
Table 105. Boster Biological Technology Corporation Information
Table 106. Boster Biological Technology Description and Business Overview
Table 107. Boster Biological Technology Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Boster Biological Technology Granulocytes Monoclonal Antibody Product
Table 109. Boster Biological Technology Recent Developments/Updates
Table 110. Biomatik Corporation Information
Table 111. Biomatik Description and Business Overview
Table 112. Biomatik Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Biomatik Granulocytes Monoclonal Antibody Product
Table 114. Biomatik Recent Developments/Updates
Table 115. Assay Genie Corporation Information
Table 116. Assay Genie Description and Business Overview
Table 117. Assay Genie Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Assay Genie Granulocytes Monoclonal Antibody Product
Table 119. Assay Genie Recent Developments/Updates
Table 120. Abbexa Corporation Information
Table 121. Abbexa Description and Business Overview
Table 122. Abbexa Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Abbexa Granulocytes Monoclonal Antibody Product
Table 124. Abbexa Recent Developments/Updates
Table 125. CLOUD-CLONE CORP. Corporation Information
Table 126. CLOUD-CLONE CORP. Description and Business Overview
Table 127. CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Product
Table 129. CLOUD-CLONE CORP. Recent Developments/Updates
Table 130. Innovative Research Corporation Information
Table 131. Innovative Research Description and Business Overview
Table 132. Innovative Research Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Innovative Research Granulocytes Monoclonal Antibody Product
Table 134. Innovative Research Recent Developments/Updates
Table 135. ZodelBiotec Ltd. Corporation Information
Table 136. ZodelBiotec Ltd. Description and Business Overview
Table 137. ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Product
Table 139. ZodelBiotec Ltd. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Granulocytes Monoclonal Antibody Distributors List
Table 143. Granulocytes Monoclonal Antibody Customers List
Table 144. Granulocytes Monoclonal Antibody Market Trends
Table 145. Granulocytes Monoclonal Antibody Market Drivers
Table 146. Granulocytes Monoclonal Antibody Market Challenges
Table 147. Granulocytes Monoclonal Antibody Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Granulocytes Monoclonal Antibody
Figure 2. Global Granulocytes Monoclonal Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Granulocytes Monoclonal Antibody Market Share by Type in 2022 & 2034
Figure 4. Recombinant Product Picture
Figure 5. Non-recombinant Product Picture
Figure 6. Global Granulocytes Monoclonal Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Granulocytes Monoclonal Antibody Market Share by Application in 2022 & 2034
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Other
Figure 14. Global Granulocytes Monoclonal Antibody Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Granulocytes Monoclonal Antibody Market Size (2024-2034) & (US$ Million)
Figure 16. Global Granulocytes Monoclonal Antibody Sales (2024-2034) & (K Units)
Figure 17. Global Granulocytes Monoclonal Antibody Average Price (US$/Unit) & (2024-2034)
Figure 18. Granulocytes Monoclonal Antibody Report Years Considered
Figure 19. Granulocytes Monoclonal Antibody Sales Share by Manufacturers in 2022
Figure 20. Global Granulocytes Monoclonal Antibody Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Granulocytes Monoclonal Antibody Players: Market Share by Revenue in 2022
Figure 22. Granulocytes Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global Granulocytes Monoclonal Antibody Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America Granulocytes Monoclonal Antibody Sales Market Share by Country (2024-2034)
Figure 25. North America Granulocytes Monoclonal Antibody Revenue Market Share by Country (2024-2034)
Figure 26. United States Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe Granulocytes Monoclonal Antibody Sales Market Share by Country (2024-2034)
Figure 29. Europe Granulocytes Monoclonal Antibody Revenue Market Share by Country (2024-2034)
Figure 30. Germany Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific Granulocytes Monoclonal Antibody Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific Granulocytes Monoclonal Antibody Revenue Market Share by Region (2024-2034)
Figure 37. China Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America Granulocytes Monoclonal Antibody Sales Market Share by Country (2024-2034)
Figure 45. Latin America Granulocytes Monoclonal Antibody Revenue Market Share by Country (2024-2034)
Figure 46. Mexico Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Granulocytes Monoclonal Antibody Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa Granulocytes Monoclonal Antibody Revenue Market Share by Country (2024-2034)
Figure 51. Turkey Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE Granulocytes Monoclonal Antibody Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Granulocytes Monoclonal Antibody by Type (2024-2034)
Figure 55. Global Revenue Market Share of Granulocytes Monoclonal Antibody by Type (2024-2034)
Figure 56. Global Granulocytes Monoclonal Antibody Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of Granulocytes Monoclonal Antibody by Application (2024-2034)
Figure 58. Global Revenue Market Share of Granulocytes Monoclonal Antibody by Application (2024-2034)
Figure 59. Global Granulocytes Monoclonal Antibody Price (US$/Unit) by Application (2024-2034)
Figure 60. Granulocytes Monoclonal Antibody Value Chain
Figure 61. Granulocytes Monoclonal Antibody Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed